Aptamer Group (APTA) Competitors GBX 0.25 -0.01 (-4.53%) As of 11:28 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock APTA vs. AOR, AREC, OPTI, POLB, SAR, IMM, RLM, NSCI, OBD, and IXIShould you be buying Aptamer Group stock or one of its competitors? The main competitors of Aptamer Group include AorTech International (AOR), Arecor Therapeutics (AREC), OptiBiotix Health (OPTI), Poolbeg Pharma (POLB), Sareum (SAR), ImmuPharma (IMM), Realm Therapeutics (RLM), NetScientific (NSCI), Oxford BioDynamics (OBD), and IXICO (IXI). These companies are all part of the "biotechnology" industry. Aptamer Group vs. AorTech International Arecor Therapeutics OptiBiotix Health Poolbeg Pharma Sareum ImmuPharma Realm Therapeutics NetScientific Oxford BioDynamics IXICO AorTech International (LON:AOR) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership, community ranking and valuation. Is AOR or APTA more profitable? AorTech International has a net margin of 0.00% compared to Aptamer Group's net margin of -343.95%. AorTech International's return on equity of 0.00% beat Aptamer Group's return on equity.Company Net Margins Return on Equity Return on Assets AorTech InternationalN/A N/A N/A Aptamer Group -343.95%-205.63%-44.96% Which has preferable valuation & earnings, AOR or APTA? AorTech International has higher earnings, but lower revenue than Aptamer Group. Aptamer Group is trading at a lower price-to-earnings ratio than AorTech International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAorTech International£539K0.00N/A-£3.70N/AAptamer Group£4.12M1.22-£14.17M-£0.71-0.36 Does the media prefer AOR or APTA? In the previous week, AorTech International's average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score. Company Overall Sentiment AorTech International Neutral Aptamer Group Neutral Do insiders & institutionals have more ownership in AOR or APTA? 11.7% of Aptamer Group shares are owned by institutional investors. 13.2% of Aptamer Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in AOR or APTA? AorTech International received 77 more outperform votes than Aptamer Group when rated by MarketBeat users. CompanyUnderperformOutperformAorTech InternationalOutperform Votes7767.54% Underperform Votes3732.46% Aptamer GroupN/AN/A SummaryAptamer Group beats AorTech International on 5 of the 9 factors compared between the two stocks. Remove Ads Get Aptamer Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APTA vs. The Competition Export to ExcelMetricAptamer GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£5.03M£115.11M£5.55B£2.57BDividend YieldN/A3.69%5.35%4.95%P/E Ratio-0.363.1523.49139.96Price / Sales1.224,112.68367.96262,597.20Price / CashN/A13.0138.1627.90Price / Book1.1835.646.634.54Net Income-£14.17M-£87.82M£3.20B£5.76B7 Day Performance-11.85%-4.59%-6.41%0.34%1 Month Performance-36.75%57.94%-1.54%5.74%1 Year Performance-56.00%82.00%7.23%107.79% Aptamer Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APTAAptamer GroupN/AGBX 0.25-4.5%N/A-53.9%£5.03M£4.12M-0.3637Gap DownAORAorTech InternationalN/AN/AN/AN/A£19.99M£539,000.00-33.383ARECArecor TherapeuticsN/AGBX 49flatN/A-70.0%£18.50M£6.04M-1.7310Gap DownOPTIOptiBiotix HealthN/AGBX 16.52-6.9%N/A-21.5%£16.18M£590,009.23-5.231Gap DownHigh Trading VolumePOLBPoolbeg PharmaN/AGBX 2.79-2.2%N/A-72.3%£14.33MN/A0.0012SARSareumN/AGBX 11.45-6.5%N/A+19.6%£14.30MN/A-2.713,211Earnings ReportPositive NewsGap UpIMMImmuPharmaN/AGBX 3.33-3.2%N/A+45.9%£14.16M£-71,310.29-5.7613Gap DownRLMRealm TherapeuticsN/AN/AN/AN/A£13.41M£501,919.00-0.66N/ANSCINetScientificN/AN/AN/AN/A£12.81M£1.45M-486.3626OBDOxford BioDynamicsN/AGBX 0.50+5.3%N/A-94.9%£9.43M£5.75M-0.0945Gap DownIXIIXICON/AGBX 9.20+8.2%N/AN/A£8.53M£11.50M-2.3889 Remove Ads Related Companies and Tools Related Companies AorTech International Alternatives Arecor Therapeutics Alternatives OptiBiotix Health Alternatives Poolbeg Pharma Alternatives Sareum Alternatives ImmuPharma Alternatives Realm Therapeutics Alternatives NetScientific Alternatives Oxford BioDynamics Alternatives IXICO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:APTA) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptamer Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptamer Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
